Rankings
▼
Calendar
ESLA Q2 2021 Earnings — Estrella Immunopharma, Inc. Revenue & Financial Results | Market Cap Arena
ESLA
Estrella Immunopharma, Inc.
$53M
Q2 2021 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
$0
Net Income
-$3,555
EPS (Diluted)
$-0.00
Cash Flow
Operating Cash Flow
-$6,055
Free Cash Flow
-$6,055
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$3M
Total Liabilities
$3M
Stockholders' Equity
$20,626
Cash & Equivalents
$11,018
← FY 2021
All Quarters
Q3 2021 →
